Mylan Pharmaceuticals and Teva Pharmaceuticals are two of the current manufacturers of generic Femara (letrozole). The generic version comes in one strength and is considered equivalent to the brand-name version of the drug. However, generic drugs are allowed to have different inactive ingredients, which could pose problems for people with certain allergies or sensitivities.
An Overview of Generic FemaraFemara® (letrozole) is a prescription medication used to treat breast cancer in postmenopausal women. It is part of a group of medications called aromatase inhibitors.
Brand-name Femara is manufactured by Novartis Pharmaceuticals. However, the medication is also available in generic form.
Like brand-name Femara, the generic version comes in just one strength -- Letrozole 2.5-mg tablets. It is made by various generic manufacturers, including but not limited to:
- Accord Healthcare, Inc.
- Mylan Pharmaceuticals, Inc.
- Qualitest Products, Inc.
- Teva Pharmaceuticals.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns a rating to each one.
An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. Generic letrozole has an "AB" rating, meaning it should be equivalent to Femara.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.